Results 141 to 150 of about 12,242 (218)

Whole-Genome sequencing of Chikungunya Virus (CHIKV) from Pakistan: Detection of the East/Central/South African (ECSA) genotype during the 2024 outbreak in Mansehra. [PDF]

PLoS One
Umair M, Yasir M, Jamal Z, Hakim R, Saeed SY, Salman M, Iqbal A, Khan MQ, Khanzada F, Javed Y.   +9 more
europepmc   +1 more source

Global Proteome Analysis of a Three-Dimensional Human Chondrocyte Cell Culture System Infected with Chikungunya Virus (CHIKV) Reveals Distinct Immune and Inflammatory Signatures. [PDF]

ACS Omega
Hasan A, Sharma G, Majumder N, Chaudhary S, Mehta D, Vaishya R, Ghosh S, Sunil S.   +7 more
europepmc   +1 more source

Cell Host Microbe [PDF]

Neutralizing antibodies (NAbs) are traditionally thought to inhibit virus infection by preventing virion entry into target cells. In addition, antibodies can engage Fc receptors (FcRs) on immune cells to activate antiviral responses.

core  

Identification of RACK1 as a novel regulator of non-structural protein 4 of chikungunya virus: RACK1 regulates CHIKV nsP4

Chikungunya virus (CHIKV) is a neglected arthropod-borne and anthropogenic alphavirus. Over the past two decades, the CHIKV distribution has undergone significant changes worldwide, from the original tropics and subtropics regions to temperate regions, which has attracted global attention.
Yan, Yao, Zhang, Fengyuan, Zou, Meng, Chen, Hongyu, Xu, Jingwen, Lu, Shuaiyao, Liu, Hongqi   +6 more
openaire   +1 more source

Epidemiology, seroprevalence, and circulation of Chikungunya virus in Southern Africa (SADC region): A systematic review. [PDF]

PLoS Negl Trop Dis
Lamula S, Ramatsitsi N, Buwa-Komoreng L.
europepmc   +1 more source

Genomic epidemiology reveals the origins and transmission dynamics of chikungunya virus in China. [PDF]

Infect Dis Poverty
Chang W, Zheng M, Jiang Y, Liu G, Chen X, Wang X, Guo Y, Liu L, Feng Y, Xia X.   +9 more
europepmc   +1 more source

Rapid differentiation of VLA1553 and wild-type ECSA chikungunya strains in the context of an IXCHIQ vaccination campaign. [PDF]

Emerg Microbes Infect
Pezzi L, Frumence E, Wesselmann K, Mollé G, Falgous L, Ayhan N, Klitting R, Durand GA, Grard G, Mosnier E, Gérardin P, Nougairède A, Charrel R, Jaffar-Bandjee MC, de Lamballerie X.   +14 more
europepmc   +1 more source

Epidemic features and potential impact of vaccine campaigns on the 2025 chikungunya outbreak in southern China: a mathematical modelling study. [PDF]

New Microbes New Infect
Zheng Q, Ding Y, Wang X, Yang Y, Meng Q, Al-Tawfiq JA, Zhong Z, Wang W, Pan Q.   +8 more
europepmc   +1 more source

Analysis of imported Chikungunya cases in China from 2006 to 2026. [PDF]

Front Microbiol
Wang J, Sun W, Zhao J, Zhang L.
europepmc   +1 more source